EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Inflammatory bowel disease through the lens of microbe-host interactions: immunomodulation, metabolic effects, and genetic susceptibility in microbiota dysbiosis

Qinghua Zou, Wumiao Zhang, Hua Xie, Shuyan Ying, Xueliang Zeng, Yihang Yao, Dingcheng Zeng, Jiulong Wang, Cheng Zhang, Fan Meng

Frontiers in Cellular and Infection Microbiology · 16.02.2026 · 16

DOI: 10.3389/fcimb.2026.1745929 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 16.02.2026. Verfasst von Qinghua Zou und 9 weiteren Autor:innen. Beteiligte Einrichtung: The First Clinical Medical College of Gannan Medical University, Ganzhou, Jiangxi, China. Hauptthemen laut MEDLINE: Dysbiosis, Inflammatory Bowel Diseases, Genetic Predisposition to Disease, Immunomodulation. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 155 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inflammatory bowel disease (IBD), including ulcerative colitis, Crohn’s disease, and inflammatory bowel disease-unclassified, is a complex intestinal disease influenced by microbial factors, genetic and environmental. IBD has become a global disease with an increasing prevalence, endangering human health worldwide. Through its interactions with host immunity, bacterial metabolites, and genetic components, the intestinal microbiome plays a crucial role in initiating and advancing IBD. Treatment for IBD includes not only corticosteroids, aminosalicylates, antibiotics, TNF-α, α4β7 integrins, IL-12/23 antibodies, and small molecule antibodies, but also complementary and alternative medical therapies such as probiotics and prebiotics. This review primarily explores the relationship between dysbiosis of the microbiota and IBD, including the immune system, metabolites, and genetics related to microorganisms, to provide a deeper and more systematic understanding of the mechanisms linking microbial imbalance to IBD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DysbiosisInflammatory Bowel DiseasesGenetic Predisposition to DiseaseImmunomodulationGastrointestinal MicrobiomeHost Microbial InteractionsHost-Pathogen InteractionsHumansAnimals

Stichwörter der Autor:innen

dysbiosis of microbial communitygeneimmune systeminflammatory bowel diseasemetabolites

Autor:innen und Institutionen

  • The First Clinical Medical College of Gannan Medical University, Ganzhou, Jiangxi, China.
  • The First Affiliated Hospital of Gannan Medical University, Ganzhou, Jiangxi, China.
  • The Yuebei People's Hospital, Shaoguan, Guangdong, China.
  • The Fifth Affiliated Hospital of Southern Medical University, Guangzhou, China.

Zitieren

APA

Zou, Q., Zhang, W., Xie, H., Ying, S., Zeng, X., Yao, Y., Zeng, D., Wang, J., Zhang, C., & Meng, F. (2026). Inflammatory bowel disease through the lens of microbe-host interactions: immunomodulation, metabolic effects, and genetic susceptibility in microbiota dysbiosis. Frontiers in Cellular and Infection Microbiology, 16. https://doi.org/10.3389/fcimb.2026.1745929

Vancouver

Zou Q, Zhang W, Xie H, Ying S, Zeng X, Yao Y, et al. Inflammatory bowel disease through the lens of microbe-host interactions: immunomodulation, metabolic effects, and genetic susceptibility in microbiota dysbiosis. Frontiers in Cellular and Infection Microbiology. 2026;16. doi:10.3389/fcimb.2026.1745929

BibTeX
@article{Zou2026,
  author = {Zou, Qinghua and Zhang, Wumiao and Xie, Hua and Ying, Shuyan and Zeng, Xueliang and Yao, Yihang and Zeng, Dingcheng and Wang, Jiulong and Zhang, Cheng and Meng, Fan},
  title = {Inflammatory bowel disease through the lens of microbe-host interactions: immunomodulation, metabolic effects, and genetic susceptibility in microbiota dysbiosis},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2026},
  volume = {16},
  doi = {10.3389/fcimb.2026.1745929}
}
Kostenlos starten →